Clinical Trials Logo

Clinical Trial Summary

High Frequency Oscillation (HFO) on ElectroCorticoGraphy (ECoG) has been identified as a new biomarker for epileptogenic tissue. The purpose of this study is to see if epilepsy surgery guided by the combination of HFO on ECoG and standard clinical practice can result in a greater likelihood of seizure freedom, versus standard clinical practice alone, without HFOs.


Clinical Trial Description

Intra-operative electrocorticography (ECoG), based on interictal spike and spike patterns, is performed to optimize delineation of the epileptogenic tissue in the operating room during epilepsy surgery. Similarly, extra-operative electrocorticography is often recorded over days to weeks with intracranial grids and depth electrodes, when the epileptogenic zone is not clearly localized with non-invasive studies and/or with intra-operative ECoG. Surgical resection following extra-operative ECoG is then "tailored' by the seizure onset zone as the gold standard. High frequency oscillations have been identified as a more precise biomarker for epileptogenic tissue. The aim of this double-blind randomized surgical trial is to determine if HFO- tailored surgery combining HFOs and current standard of care, compared to current standard of care alone, will lead to a better seizure outcome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03790280
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date November 29, 2018
Completion date July 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT00646711 - Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase 2
Recruiting NCT04253379 - Social Cognition in Pediatric Epilepsy N/A